Vera Therapeutics Financial Overview
Vera Therapeutics's market cap is currently $3.40B. The company's EPS TTM is $-1.26; its P/E ratio is -11.96; Vera Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-1.30. See an overview of income statement, balance sheet, and cash flow financials.
